← All collections

Research collection

Sexual health

1 compounds · 2 indexed papers

Bremelanotide

Approved drug

PT-141 · Vyleesi

An MC4R agonist that acts on central pathways governing sexual desire rather than on blood flow. Approved on the basis of two phase III randomised trials in premenopausal women.

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

FDA approved in June 2019 as Vyleesi for acquired, generalised hypoactive sexual desire disorder in premenopausal women. Not EMA approved.

Primary sources